Hemodynamic effects of adjunct arginine vasopressin to norepinephrine in septic shock: insights from a prospective multicenter registry study
Abstract Background The Surviving Sepsis Campaign guidelines suggest adding arginine vasopressin (AVP) when norepinephrine (NE) doses reach 0.25–0.50 µg/kg/min in septic shock patients. However, relying solely on a NE threshold has limitations, as other factors may be valuable in guiding AVP therapy...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier
2025-04-01
|
| Colección: | Annals of Intensive Care |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1186/s13613-025-01472-w |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
